Atopic Dermatitis Clinical Trials in Santa Monica, California

4 studies are recruiting for atopic dermatitis in Santa Monica, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

    The purpose of the study is to evaluate the dose-response relationship of galvokimig compared with placebo in study participants with moderate-to-severe atopic dermatitis (AtD).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Atd002 52008, Santa Monica, California
    Locations
    68 in total
    Run by
    UCB Biopharma SRL

    See if you can join NCT07277660 on ClinicalTrials.gov

  2. A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

    The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have severe itching and rashes on the skin. The study is seeking participants who: 1. A…

    Stage
    Phase 2
    Ages
    18 to 64
    Site
    Clinical Science Institute, Santa Monica, California
    Locations
    23 in total
    Run by
    Pfizer

    See if you can join NCT07216027 on ClinicalTrials.gov

  3. Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

    This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

    Stage
    Phase 2
    Ages
    18 to 100
    Site
    Novartis Investigative Site, Santa Monica, California
    Locations
    105 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT06947993 on ClinicalTrials.gov

  4. Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

    The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.

    Stage
    Not phased
    Ages
    12 and older
    Site
    Galderma Investigational Site 7064, Santa Monica, California
    Locations
    108 in total
    Run by
    Galderma R&D

    See if you can join NCT06988605 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.